Sensitization from transfusion in patients awaiting primary kidney transplant.
about
Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010).HLA sensitisation: can it be prevented?Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.Should target hemoglobin levels in dialysis patients be lowered to 9-10 g/dl?Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease.Leukoreduced red blood cell transfusions do not induce platelet glycoprotein antibodies in patients with sickle cell disease.Spectrum of anemia after kidney transplantation: pathophysiology and therapeutic implications.Clinical pancreatic islet transplantation.Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study.ESRD Payment Reform: First Do No Harm.ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption.Complement-dependent cytotoxicity and Luminex technology for human leucocyte antigen antibody detection in kidney transplant candidates exposed to different sensitizing events.The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis-dependent chronic kidney disease patients with and without anemia in the United States.Anemia in chronic kidney disease.
P2860
Q34857944-9EB0D605-3D16-411C-88A5-5539A7550FF6Q35097898-5A006ED0-B436-4E64-9D16-45B308C71279Q35811966-09BCC7D0-1795-4B1A-8D58-EC095D05C4B3Q38199174-1CFB0415-19FB-4FC1-BFE4-5A9D9A845932Q38436060-F9517456-6297-4406-81E0-50CF63D91085Q38844594-1807D76F-B73D-477E-B960-0B0D102CC266Q38900551-F83712C5-2B8A-4B96-A99C-225028072758Q39005220-046631B7-31CB-4B4E-B172-96F792B74000Q40452726-7F134733-02CD-4DF5-8556-6FF06D3EA0A5Q42389549-D0B47E1D-7616-4087-94A7-DC64FB64133FQ43713630-25249636-241E-4AA3-B84F-C549EF75A513Q47167963-C1E5D2AE-972F-4A28-A755-B2AC193C0B26Q50042370-A194D0FD-6BCD-4F15-BA04-F7509B1AB364Q52665595-05D59042-9844-42D4-9011-1B05C73D810AQ53078854-81419E6E-7859-46E0-9655-BFC296241232Q53354670-29B15802-831F-45A4-A809-8AC1227101CD
P2860
Sensitization from transfusion in patients awaiting primary kidney transplant.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sensitization from transfusion in patients awaiting primary kidney transplant.
@en
Sensitization from transfusion in patients awaiting primary kidney transplant.
@nl
type
label
Sensitization from transfusion in patients awaiting primary kidney transplant.
@en
Sensitization from transfusion in patients awaiting primary kidney transplant.
@nl
prefLabel
Sensitization from transfusion in patients awaiting primary kidney transplant.
@en
Sensitization from transfusion in patients awaiting primary kidney transplant.
@nl
P2093
P2860
P356
P1476
Sensitization from transfusion in patients awaiting primary kidney transplant.
@en
P2093
Brian D Bradbury
Calvin D Lou
Deborah Kim
Dolly B Tyan
Glenn M Chertow
Jeffrey Petersen
Jerome Rossert
Julie M Yabu
Matthew W Anderson
P2860
P304
P356
10.1093/NDT/GFT362
P407
P577
2013-09-05T00:00:00Z